CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development

Blood

Volumn 119, Issue 7, 2012, Pages 1747-1756

  Finney, Brenda A ^a   Schweighoffer, Edina ^b   Navarro Núñez, Leyre ^a   Bénézech, Cecile ^c   Barone, Francesca ^c   Hughes, Craig E ^a   Langan, Stacey A ^a   Lowe, Kate L ^a   Pollitt, Alice Y ^a   Mourao Sa, Diego ^d   Sheardown, Steve ^e,f   Nash, Gerard B ^a   Smithers, Nicholas ^e   Reis E Sousa, Caetano ^d   Tybulewicz, Victor L J ^b   Watson, Steve P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e GLAXOSMITHKLINE   (United Kingdom)

^f Takeda Cambridge   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DECTIN 1; PROTEIN KINASE SYK;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; BRAIN DEVELOPMENT; CELL ADHESION; CELL MIGRATION; CEREBROVASCULAR DISEASE; ENDOTHELIUM CELL; LYMPHANGIOGENESIS; MEGAKARYOCYTE; MOUSE; NONHUMAN; PERINATAL DEVELOPMENT; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEPLETION; THROMBOCYTE;

EID: 84857565263     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-09-380709     Document Type: Article

References (51)

1. Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell. 2010;140(4):460-476.
2. Turner M, Joseph Mee P, Costello PS, et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature. 1995;378(6554):298-302.
3. Cheng AM, Rowley B, PaoW, Hayday A, Bolen JB, Pawson T. Syk tyrosine kinase required for mouse viability and B-cell development. Nature. 1995;378(6554):303-306.
4. Abtahian F, Guerriero A, Sebzda E, et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science. 2003;299(5604):247-251. (Pubitemid 36125210)
5. Ichise H, Ichise T, Ohtani O, Yoshida N. Phospholipase C gamma 2 is necessary for separation of blood and lymphatic vasculature in mice. Development. 2009;136(2):191-195.
6. Suzuki-Inoue K, Fuller GLJ, Garcia A, et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood. 2006;107(2):542-549. (Pubitemid 43076377)
7. Colonna M, Samaridis J, Angman L. Molecular characterization of two novel C-type lectin-like receptors, one of which is selectively expressed in human dendritic cells. Eur J Immunol. 2000;30(2):697-704. (Pubitemid 30098866)
8. Kerrigan AM, Dennehy KM, Mourao-Sa D, et al. CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils. J Immunol. 2009;182(7):4150-4157.
9. Mourao-Sa D, Robinson MJ, Zelenay S, et al. CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses. Eur J Immunol. 2011;41(10):3040-3053.
10. Watson SP, Herbert JMJ, Pollitt AY. GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost. 2010;8(7):1456-1467.
11. Suzuki-Inoue K, Inoue O, Ozaki Y. Novel platelet activation receptor CLEC-2: from discovery to prospects. J Thromb Haemost. 2011;9(Suppl 1):44-55.
12. Spalton JC, Mori J, PollittAY, Hughes CE, Eble JA, Watson SP. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets. J Thromb Haemost. 2009;7(7):1192-1199.
13. Hughes CE, Pollitt AY, Mori J, et al. CLEC-2 activates Syk through dimerization. Blood. 2010;115(14):2947-2955.
14. May F, Hagedorn I, Pleines I, et al. CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood. 2009;114(16):3464-3472.
15. Suzuki-Inoue K, Inoue O, Ding G, et al. Essential in vivo roles of the C-type lectin receptor CLEC-2. J Biol Chem. 2010;285(32):24494-24507.
16. Hughes CE, Navarro-Núñez L, Finney BA, Mourão- Sá D, Pollitt AY, Watson SP. CLEC-2 is not required for platelet aggregation at arteriolar shear. J Thromb Haemost. 2010;8(10):2328-2332.
17. Suzuki-Inoue K, Kato Y, Inoue O, et al. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem. 2007;282(36):25993-26001. (Pubitemid 47443800)
18. Christou CM, Pearce AC, Watson AA, et al. Renal cells activate the platelet receptor CLEC-2 through podoplanin. Biochem J. 2008;411(1):133-140. (Pubitemid 351482355)
19. Schacht V, Ramirez MI, Hong YK, et al. T1 alpha/ podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 2003;22(14):3546-3556. (Pubitemid 36898332)
20. Uhrin P, Zaujec J, Breuss JM, et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood. 2010;115(19):3997-4005.
21. Carramolino L, Fuentes J, Garcia-Andres C, Azcoitia V, Riethmacher D, Torres M. Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ Res. 2010;106(7):1197-1201.
22. Bertozzi CC, Schmaier AA, Mericko P, et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood. 2010;116(4):661-670.
23. Tang T, Li L, Tang J, et al. A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol. 2010;28(7):749-755.
24. Chagraoui H, Kassouf M, Banerjee S, et al. SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis. Blood. 2011;118(3):723-735.
25. Mocsai A, Ruland J, Tybulewicz VLJ. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol. 2010;10(6):387-402.
26. Sebzda E, Hibbard C, Sweeney S, et al. Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development. Dev Cell. 2006;11(3):349-361. (Pubitemid 44283944)
27. Bohmer R, Neuhaus B, Buhren S, et al. Regulation of developmental lymphangiogenesis by Syk(+) leukocytes. Dev Cell. 2010;18(3):437-449.
28. Tiedt R, Schomber T, Hao-Shen H, Skoda RC. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood. 2007;109:1503-1506. (Pubitemid 46239582)
29. de Boer J, Williams A, Skavdis G, et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol. 2003; 33(2):314-325. (Pubitemid 36267595)
30. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8(4):265-277. (Pubitemid 29523965)
31. Gustafsson E, Brakebusch C, Hietanen K, Fassler R. Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J Cell Sci. 2001;114(Pt 4):671-676. (Pubitemid 32237139)
32. Caton ML, Smith-Raska MR, Reizis B. Notch- RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J Exp Med. 2007;204(7):1653-1664. (Pubitemid 47048031)
33. Saijo K, Schmedt C, Su IH, et al. Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development. Nat Immunol. 2003;4(3):274-279. (Pubitemid 36322138)
34. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophot Int. 2004;11(7):36-42.
35. Aparicio-Vergara M, Shiri-Sverdlov R, de Haan G, Hofker MH. Bone marrow transplantation in mice as a tool for studying the role of hematopoietic cells in metabolic and cardiovascular diseases. Atherosclerosis. 2010;213(2):335-344.
36. Makinen T, Veikkola T, Mustjoki S, et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 2001;20(17):4762-4773. (Pubitemid 32848629)
37. Xu M-j Matsuoka S, Yang F-C, et al. Evidence for the presence of murine primitive megakarycytopoiesis in the early yolk sac. Blood. 2001;97(7):2016- 2022.
38. Xie X, Chan RJ, Johnson SA, et al. Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs. Blood. 2003;101(4):1329-1335. (Pubitemid 36182503)
39. Tober J, Koniski A, McGrath KE, et al. The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis. Blood. 2007;109(4):1433-1441. (Pubitemid 46239574)
40. Ramirez MI, Millien G, Hinds A, Cao YX, Seldin DC, Williams MC. T1 alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev Biol. 2003;256(1):61-72. (Pubitemid 36332205)
41. Warburton D, El-Hashash A, Carraro G, et al. Lung organogenesis. Curr Top Dev Biol. 2010;90:73-158.
42. Humphreys PW, Normand ICS, Reynolds EOR, Strang LB. Pulmonary lymph flow and the uptake of liquid from the lungs of the lamb at the start of breathing. J Physiol-London. 1967;193(1):1-29.
43. Pardridge WM. Drug transport in brain via the cerebrospinal fluid. Fluids Barriers CNS. 2011;8(1):7.
44. Williams MC, Cao Y, Hinds A, Rishi AK,Wetterwald A. T1 alpha protein is developmentally regulated and expressed by alveolar type I cells, choroid plexus, and ciliary epithelia of adult rats. Am J Respir Cell Mol Biol. 1996;14(6):577-585. (Pubitemid 126442949)
45. Kaufmann MH. The Atlas of Mouse Development. London, United Kingdom: Elsevier; 1992.
46. Martin-Villar E, Megias D, Castel S, Yurrita MM, Vilaro S, Quintanilla M. Podoplanin binds ERM proteins to activate RhoA and promote epithelialmesenchymal transition. J Cell Sci. 2006;119(Pt 21):4541-4553. (Pubitemid 44830653)
47. Navarro A, Perez RE, Rezaiekhaligh MH, Mabry SM, Ekekezie II. Polarized migration of lymphatic endothelial cells is critically dependent on podoplanin regulation of Cdc42. Am J Physiol Lung Cell Mol Physiol. 2011;300(1):L32-L42.
48. Navarro A, Perez RE, Rezaiekhaligh M, Mabry SM, Ekekezie II. T1 alpha/podoplanin is essential for capillary morphogenesis in lymphatic endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2008;295(4):L543-L551.
49. Cueni LN, Chen L, Zhang H, et al. Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin. Blood. 2010;116(20):4376-4384.
50. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, et al. Beta3-integrin- deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. 1999;103(2):229-238. (Pubitemid 29053141)
51. Nieswandt B, Brakebusch C, Bergmeier W, et al. Glycoprotein VI but not alpha 2 beta 1 integrin is essential for platelet interaction with collagen. EMBO J. 2001;20(9):2120-2130. (Pubitemid 32410582)